Medication info
Pitaterol Tablets 4 mg (Pitavastatin Calcium Hydrate)

Pitaterol Tablets 4 mg (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4.41mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Yellow round film-coated tablet with a line in the center
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202007583 · Approved 2020.11.05 · Insurance code 646005190

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL-cholesterol levels is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL-cholesterol levels, the treatment goal, and the patient's response. The therapeutic effect of this drug is maintained with continued administration.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo-B protein
  • elevated triglyceride levels
View approved original text

This medication assists dietary management for patients with primary hypercholesterolemia and mixed dyslipidemia, effectively lowering elevated total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels, while helping to increase HDL-cholesterol levels. This contributes to improving blood lipids and maintaining cardiovascular health.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL-cholesterol levels is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL-cholesterol levels, the treatment goal, and the patient's response. The therapeutic effect of this drug is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medication, those with active liver disease, severe hepatic impairment, biliary obstruction, and those taking cyclosporine should not take this medication. Additionally, this medication should not be used in patients with myopathy, pregnant women or those who may become pregnant, nursing women, and children. This medication contains lactose, so lactose-intolerant patients should also avoid its use. Patients with kidney function abnormalities or a history of liver impairment should use this medication with caution. Especially when taken with fibrates or niacin, there can be a risk of muscle damage and kidney function deterioration, so caution is required. Caution is also warranted for patients who consume alcohol excessively or have a history of hypothyroidism or muscle disorders. Elderly patients and those with allergies to specific dye components also require careful monitoring. This medication can cause various adverse reactions, including muscle pain, weakness, liver function abnormalities, and allergic reactions. Rhabdomyolysis, which involves the breakdown of muscle tissue, can occur; therefore, if muscle pain or weakness occurs, one should immediately discontinue use. Regular liver function tests should be performed, and if abnormalities are detected, the medication should be stopped, and appropriate action should be taken. Since this medication is used for the treatment of hypercholesterolemia, it is important to conduct thorough examinations and dietary and exercise regimens prior to administration. During treatment, blood lipid levels should be monitored regularly, and if no effect is observed, use should be discontinued. Patients with impaired liver function should adjust the dosage, and liver function tests should also be performed periodically after medication use. This medication interacts with certain drugs, increasing the risk of kidney damage and muscle injury when used together. In particular, it should not be taken with cyclosporine, fibrates, or niacin, and a sufficient interval should be maintained from the use of cholestyramine. Additionally, co-administration of this medication with fusidic acid is not recommended, and if unavoidable, strict monitoring is necessary. Elderly patients have a higher risk of experiencing adverse reactions due to decreased bodily function, so dosage adjustments and caution are required. Pregnant women, women who may become pregnant, and nursing women should not take this medication. It can have serious effects on the fetus, so administration should be discontinued immediately if pregnancy occurs. The safety and efficacy of this medication in children have not been established, so its use is not recommended. When taking this medication, it is advisable not to split the tablets but to swallow them whole, and to store them out of reach of children. Furthermore, medications should not be transferred from their original container to another container, as this is to prevent misuse or deterioration in quality.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 80 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • feeling of heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • discomfort in the stomach
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • fatigue
  • palpitations
  • tiredness
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid level
  • increased serum potassium and phosphorus
  • dysgeusia
  • positive antinuclear antibodies
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin numbness
  • insomnia
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • asthenia
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1°C and 30°C. This way, the medication's efficacy and safety can be maintained.

Appearance and packaging

Appearance

Yellow round film-coated tablet with a line in the center

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.